(Date:12/1/2009)...1 PDL BioPharma, Inc. (P...nce for the fourth quarter ended December 31, 2009...9 million for the fourth quarter of 2008. Included...wo installment payments of $12.5 million from Alex... was a one-time $1.8 million payment from Genentec...
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Industrial Enzymes - A Global Market Re...Industrial-Enzymes---A-Global-Market-Report.html ...th few strong players and a host of small supplier...tion and commoditization characterize the industry...
(Date:12/1/2009)...Newswire/ -- Harvest Technologies Corp. ( www.harv...pany sponsored 60-patient clinical trial conducted...ia using the company,s BMAC System to treat patien... (CLI). Sri Ramachandra Medical Center is a Harvar...ed in Chennai, India and one of the largest privat...
(Date:12/1/2009)... Richard Gephardt Brings Together A-List from New ...r "Best and Brightest Forum on Medical Innovation...Newswire/ -- Several of New Jersey,s most prominen...e and technology gathered today at the Liberty Sci...nnovation in New Jersey, and throughout the United...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5...2 Edwards Lifesciences,Corporation (NYSE: EW ), ...at advanced cardiovascular disease, today announce...ueli School of Engineering at the,University of Ca...nces,Center for Advanced Cardiovascular Technology...veloping the next generation of cardiovascular,dev...
...., Sept. 12 ABR-Affinity,BioReagents, a leading g...,the research antibody marketplace through distrib...tech Corporation. Complementing existing distribu...rontier, ABR-Affinity BioReagents today finalized ... a manufacturer of antibodies,focusing on gene fun...
... Two new white papers detailing,sterility testing...om,Microtest ( http://www.microtestlabs.com ). The... device manufacturers and one which is specialized...neral concepts and,problems associated with steril...ogies. For medical device manufacturers, sterilit...
Other Biology Technology:Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology 2ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies 2Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2...proteins are the bad guys that help bacterial path...ing the body,s immune system. In essence, they kn...he cell,s alarm system. , Now, researchers at the ...of Medicine have identified a novel molecular targ...eral effectors of the bacteria Yersinia – the path...
...ge research has found that a new gene therapy can ... reduce long-term damage to the affected joints, a... Arthritis and Rheumatism. While the study was don...ed to develop osteoarthritis like humans, with the...likely to develop the disease, the authors said. I...
...tically engineered to lack a single enzyme in thei...mal cousins, and are quicker to figure out that th...hers at UT Southwestern Medical Center has found. ...tion of the journal Nature Neuroscience , reveal ...ght serve in humans as a target for treating disor...
Other Biology News:How plague-causing bacteria disarm host defense 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4'Smart' mice teach scientists about learning process, brain disorders 2Rhesus Serum from Innovative Research
Rabbit Anti-Human DBP Polyclonal antibody, Unconjugated from Aviva Systems Biology
Porcine Serum from Lifeblood Medical, Inc.
... DCTD_HUMAN GI Number: 4503277 Accession Number:...pplies the nucleotide substrate for thymidylate sy...+ NH 3 . SUBUNIT: Homohexamer. SIMILARITY: Belongs...hia Coli; Lymphadenopathy; Fungi; Lymphoma; Myelog...
Biology Products: